US showcase for Aussie gene damage research
Monday, 25 June, 2001
CSIRO scientists have found a quick and reliable technique for assessing gene damage.
"Genetic damage is a significant health issue because it is thought to underpin the development of cancer and related degenerative diseases in humans," says CSIRO researcher Dr Michael Fenech.
The technique has many exciting applications including the development of personalised radiotherapy treatments for cancer patients and the design of diets that may help prevent cancer.
The project will be among some of Australia's hottest biotechnology research being showcased in the US next week (June 24-27) at Bio2001. Bio2001 is currently the world's largest conference and exhibition for biotechnology.
CSIRO research being featured will range from the search for new drugs and better disease diagnosis to new ways to combat agricultural problems.
"Bio attracts some of the top research agencies, funding bodies and companies in the world, so being there gives us fabulous commercial and research opportunities," says CSIRO's Stephan Wellink.
Item provided courtesy of CSIRO
AXT to distribute NT-MDT atomic force microscopes
Scientific equipment supplier AXT has announced a partnership with atomic force microscope (AFM)...
Epigenetic patterns differentiate triple-negative breast cancers
Australian researchers have identified a new method that could help tell the difference between...
Combined effect of pollutants studied in the Arctic
Researchers from the Fram Centre in Norway are conducting studies in Arctic waters to determine...
